Vivonics Inc, has an interesting pedigree. When DCS acquired SBIR-involved Infoscitex Corporation in 2012, the Biomedical division of the firm was sold to employees who had set up another company for the purpose: Vivonics. Bringing with them SBIR awards on which they had already been working, the firmcontinued to focus on development of innovative technologies that improve or maintain health, or that optimize the effectiveness of humans in complex systems, from the initial concept through to viable products. Vivonics personnel are engineers and scientists representing a wide range of disciplines; biomedical, mechanical, electrical, and software engineering as well as microbiology and chemistry. Their team on almost all projects includes working class clinical and academic collaborators with each team composed of the right expertise for each project at each stage of development. Specialties: Artificial Organs, Biomedical Engineering, Biomarkers, Electronic control systems for medical devices, Medical Diagnostics, Medical robotics, MEMS and Microfluidics, Noninvasive Sensors, Physiological Monitoring, Prosthetics, Simulation for Medical Education. Developed products have included artificial organs, biomarkers, biomedical engineering, electronic control systems for medical devices, medical diagnostics, MEMS and microfluidics, noninvasive sensors, physiological monitoring, and simulation for medical education; and an implantable artificial lung based on microfluidics, an advanced socket for adapting a prosthetic leg to the amputees residual limb, a robotic device to assist with ultrasound scans, and molecular technology using advanced DNA aptamers for therapeutic and diagnostic applications. Consistent with the approach of firms to whom the principals were asociated, in January 2015, the company spun off CranioSense, LLC, which is operating as a wholly owned of Vivonics. CranioSense will further develop and commercialize I-PASS (Intracranial Pressure Assessment and Screening System), a medical device that can monitor intracranial pressure completely non-invasively.
